Oramed Pharmaceuticals, Inc. (ORMP)
3.39
-0.04
(-1.17%)
USD |
NASDAQ |
Feb 10, 16:00
3.39
0.00 (0.00%)
After-Hours: 17:30
Oramed Pharmaceuticals Shareholders Equity (Quarterly) : 203.28M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lifeward Ltd. | 12.76M |
| Bristol Myers Squibb Co. | -- |
| Instil Bio, Inc. | 120.42M |
| Nektar Therapeutics | 85.09M |
| Innoviva, Inc. | 1.010B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.49M |
| Total Liabilities (Quarterly) | 18.16M |
| Debt to Equity Ratio | 0.0042 |
| Current Ratio | 22.24 |
| Net Debt Paydown Yield | -0.07% |